Pricing Log in Create free account

Quantum Cyber N.V (QUCY) vs Exagen Inc. (XGN)

Quantum Cyber N.V and Exagen Inc. are both Diagnostics & Research companies. Exagen Inc. is the larger, with a market value of $207.4M against $95.1M — 2.2× the size. Quantum Cyber N.V grew revenue faster over the last twelve months: 69.0% against 20.8%. Quantum Cyber N.V has the higher net margin (0.00% vs −26.6%) and the lower return on invested capital (−194.0% vs −68.3%). Across the 18 metrics below, Quantum Cyber N.V leads on 9 and Exagen Inc. on 9.

Valuation

Metric QUCY XGN Diagnostics & Research median
P/E n/m n/m 35.56
P/S 21.53 2.60 4.37
P/B 0.95 15.13 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 8.36 2.60 5.51
Earnings yield (1,121.13%) (10.59%) (1.89%)
Free cash flow yield (86.11%) (4.10%) (0.15%)

Profitability

Metric QUCY XGN Diagnostics & Research median
Gross margin 56.91% 58.64% 50.89%
Operating margin 0.00% (18.58%) (8.57%)
Net margin 0.00% (26.61%) (6.37%)
Free cash flow margin 0.00% (10.66%) 0.00%
Return on equity (325.19%) (113.82%) (2.92%)
Return on assets (165.20%) (34.19%) (6.71%)
Return on invested capital (193.99%) (68.33%) 0.00%

Growth

Metric QUCY XGN Diagnostics & Research median
Revenue growth (TTM) 68.99% 20.83% 7.69%
EPS growth (last fiscal year) 87.92% (12.05%) 25.92%
Revenue growth, 5-year CAGR 1.70% 9.66% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric QUCY XGN Diagnostics & Research median
Debt to equity 0.00 2.00 0.11
Current ratio 5.56 3.18 2.02
Net debt to EBITDA (0.01) 0.68 0.70

Dividend

Metric QUCY XGN Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric QUCY XGN Diagnostics & Research median
Market cap 95.07m 207.37m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack